Rio Tinto (NYSE, LSE, ASX: RIO) faces Oyu Tolgoi reset demand as Mongolia cites 11% loan rate and disappearing dividends
Read More 2 minute read Pharma Industry News FDA grants FELIQS fast track status for FLQ-101 in ROP preventive treatment FELIQS, a multinational clinical-stage biopharmaceutical firm headquartered in Japan, has announced that its leading asset, FLQ-101, has received… byPallavi MadhirajuNovember 4, 2024